Material: Crystal

Semiconductor Chip-Themed Deal Toy

Custom deal toy marking the acquisition by UK-based Dialog Semiconductor of Adesto Technologies. Santa Clara, California-based Adesto is a provider of integrated circuits and embedded systems for the Industrial Internet of Things.

(20AKL261)
2 Images
Back View of Semiconductor Chip-Inspired Deal Tombstone

Tree-Themed Deal Toy

Custom crystal deal toy commemorating the closing of Frutas, a European agribusiness fund raised by Miura Private Equity.

(20LSS066)
1 Image

Restructuring Deal Toy

Custom deal toy commemorating the restructuring and roll-up of SmartLam, a Montana-based manufacturer of cross-laminated timber.

(20AJH054)
2 Images
Custom deal tombstone marking the restructuring and roll-up of SmartLam. Based in Columbia Falls, Montana, SmartLam specializes in cross-laminated timber, a product used in structural construction.

Computer Monitor-Themed Deal Toy

Custom deal toy marking the acquisition of a majority stake in Croatian firm Integrirani Poslovni Sustavi, operating under the brand name Remaris. Remaris specializes in software for cash registers for restaurants, cafés, and other food businesses.

(20LSS057)
2 Images
Monitor-themed deal toy commemorating the acquisition of Remaris by Polish payments firm Payten. Croatia-based Remaris specializes in the payments software for the hospitality industry.

Solar Panel-Themed Custom Crystal

Custom crystal celebrating the opening of solar power facility near Fort Calhoun, Nebraska.

(20AKL005)
1 Image

Drug-Themed Deal Tombstone

Custom deal tombstone celebrating the initial public offering by Rameda, Pharmaceuticals, a Cairo-based generic drug firm.

(9AMF339)
1 Image

REIT Merger Tombstone

Custom financial tombstone commemorating the merger between Japanese real estate investment trusts Sakura Sogo and Star Asia.

(20AKL144)
1 Image

Custom Commemorative for Drug Licensing Agreement

Custom crystal commemorative, incorporating a periodic table theme, marking a licensing and commercialization agreement for a cancer drug developed by Rockville, Maryland-based biotech firm GlycoMimetics. The agreement applies to mainland China, Hong Kong, Taiwan, and Macau.

(20ALJ071)
1 Image